Skin Disorders
Bookmark and Share
   Abscess
   Acne
   Acquired Melanocytic Nevocellular Nevi
   Acral Lentiginous Melanoma
   Acute HIV Syndrome
   Acute Lymphangitis
   Acute Sun Damage
   Adult T Cell Leukemia
   Adverse Cutaneous Drug Reactions
   Albinism
   Alopecia Areata
   Androgenetic Alopecia
   Aphthous Ulcer
   Atherosclerosis
   Bacillary Angiomatosis
   Bacterial Infections
   Basal Cell Carcinoma
   Basal Cell Nevus Syndrome
   Behcet's Syndrome
   Benign Cutaneous Neoplasms
   Calciphylaxis
   Candidiasis
   Capillary Hemangioma of Infancy
   CVL
   Cat-Scratch Disease
   Chancroid
   Chromomycosis
   Chronic Lupus Panniculitis
   Chronic Venous Insufficiency
   Clark Melanocytic Nevus
   Congenital Nevomelanocytic Nevus
   Crest Syndrome
   Cryoglobulinemia
   Cutaneous Candidiasis
   Cutaneous Larva Migrans
   Cutaneous Lupus Erythematosus
   Cutaneous and Mucocutaneous Leishmaniasis
   Cutaneous Pseudomonas Aeruginosa Infections
   Cutaneous Reactions to Arthropod Bites
   Cutaneous T Cell Lymphoma
   Dermatitis
   Dermatofibroma
   Dermatofibroma
   Dermatoheliosis
   Dermatomyositis
   Dermatophytoses
   Dermatophytosis
   Desmoplastic Melanoma
   Disseminated Coccidioidomycosis
   Disseminated Cryptococcosis
   Disseminated Gonococcal Infection
   Disseminated Intravascular Coagulation
   Donovanosis
   Drug Hypersensitivity Syndrome
   Drug-Induced Acute Urticaria
   Drug-Induced Pigmentation
   Eosinophilic Folliculitis
   Erysipelas and Cellulitis
   Erythema Infectiosum
   Erythrasma
   Erythropoietic Protoporphyria
   Exanthematous Drug Reactions
   Exfoliative Erythroderma Syndrome
   Extramammary Paget's Disease
   Eye Stye
   Fixed Drug Eruption
   Gangrenous Cellulitis
   Genital Candidiasis
   Giant Cell Arteritis
   Glucagonoma Syndrome
   Graft Versus Host Disease
   Hand-Foot-and-Mouth Disease
   Herpes Gestationis
   Herpes Simplex Virus: Genital Infections
   Herpes Simplex Virus Infection
   Herpes Simplex Virus: Infections Associated Systemic Immunocompromise
   Herpes Simplex Virus
   Herpes Zoster
   Hirsutism
   Histoplasmosis
   HIV Associated Lipodystrophy Syndrome
   Human Papillomavirus: Mucosal Infections
   Human Papillomavirus: Squamous Cell Carcinoma In Situ
   Human Papillomavirus
   Hypersensitivity Vasculitis
   Hypertrophic Scars and Keloid
   Ichthyosis
   Impetigo and Ecthyma
   Infectious Exanthems
   Infectious Folliculitis
   Infective Endocarditis
   Infestations of the Skin
   Kaposi's Sarcoma
   Kawasaki's Disease
   Keratoacanthoma


Home :: Scabies

Scabies

Scabies is an infestation by the mite Sarcoptes scabiei, usually spread by skin-to-skin contact, and characterized by generalized intractable pruritus often with minimal cutaneous findings. The diagnosis may be missed easily and should be considered in a patient of any age with persistent generalized severe pruritus.

Causes of Scabies

Hypersensitivity of both immediate and delayed types occur in the development of lesions other than burrows. For pruritus to occur, sensitization to S.scabiei must take place. Among persons with their first infection, sensitization takes several weeks to develop; after reinfestation, pruritus may occur within 24 h. Various immunocompromised states or individuals with neurologic disease predisposed to crusted Norwegian scabies. Infestation is usually by only approximately 10 mites. In contrast, the number of infesting mites in crusted scabies may exceed a million.

Symptoms of Scabies

  • Pimple-like irritations, burrows or rash of the skin, especially the webbing between the fingers; the skin folds on the wrist, elbow, or knee; the penis, the breast, or shoulder blades.
  • Intense itching, especially at night and over most of the body.
  • Small children or babies may have involvement of the face, scalp, palms of the hands, or soles of the feet.

Diagnosis

Clinical findings, confirmed, if possible, by microscopy (identification of mites, eggs, or mite feces). Assiduous search for burrows or papules should be made in every patient with severe generalized pruritus. Sometimes when the mite cannot be demonstrated, a "therapeutic test" will clinch the diagnosis.

Treatment

Principles of Treatment Infested individuals and close physical contacts should be treated at the same time, whether or not symptoms are present. Topical agents are more effective after hydration of the skin, i.e., after bathing. Application should be to all skin sites, especially the groin, around nails, behind ears, including face and scalp. Sexual partners and close personal or household contacts within last month should be examined and treated prophylactically.

Scabicides Choice of scabicide based on effectiveness, potential toxicity, cost, extent of secondary eczematization, and age of patient. Permethrin is effective and safe but costs more than lindane. Lindane is effective in most areas of the world, but resistance has been reported. Seizures have occurred when lindane was applied after a bath or used by patients with extensive dermatitis. Aplastic anemia after lindane use was also reported. No controlled studies have confirmed that two applications are better than one. Clean clothing should be put on afterwards. Clothing and bedding are decontaminated by machine-washing at 60°C. Pruritus can persist for up to 1 to 2 weeks after the end of effective therapy. After that time, cause of persistent itching should be investigated.

Recommended Regimens

Permethrin 5% Cream Applied to all areas of the body from the neck down. Wash off 8-12 h after application. Adverse events very low.

Lindane (g-Benzene Hexachloride) 1% Lotion or Cream Applied thinly to all areas of the body from the neck down; wash off thoroughly after 8h. Note: Lindane should not be used after a bath or shower, and it should not be used by persons with extensive dermatitis, pregnant or lactating women, and children younger than 2 years. Mite resistance to lindane has developed in North, Central, and South America and Asia. Low cost makes lindane a key alternative in many countries.

Alternative Regimens

Crotamiton 10% Cream Applied thinly to the entire body from the neck down, nightly for 2 consecutive nights; wash off 24 h after second application.

Sulfur 2 to 10% in Petrolatum Applied to skin for 2 to 3 days.

Benzyl Benzoate 10 and 25% Lotions Several regimens are recommended: swabbing only once; two applications separated by 10 min, or two applications with a 24-h or 1-week interval. 24 h after application, preparation should be washed off and clothes and bedding changed. The compound is an irritant and can induce pruritic irritant dermatitis, especially on face and genitalia.

Benzyl Benzoate with Sulfiram Several regimens are recommended: swabbing only once:

Esdepallethrine .63%

Malathion .5% lotion

Sulfiram 25% lotion Can mimic effect of disulfiram; no alcoholic drinks should be consumed for at least 48 h.

Ivermectin .8% lotion

Systemic Ivermectin Ivermectin, 200 µg/kg PO; single dose reported to be very effective for common as well as crusted scabies in 15 to 30 days. Two to three doses, separated by 1 to 2 weeks, usually required for heavy infestation or in immunocompromised individuals. May effectively eradicate epidemic or endemic scabies in institutions such as nursing homes, hospitals, and refugee camps. Not approved by USFDA or European Drug Agency.

Infants, Young Children, Pregnant/Lactating Women Permethrin or crotamiton regimens or precipitated sulfur ointment should be used with application to all body areas. Lindane and ivermectin should not be used.

Crusted Scabies Scabicides Lindane should be avoided because of risk of CNS toxicity. Multiple scabicide applications are required to all the skin. Treatment also should also be directed at removing scale/crusts that protect mites from scabicide; nails should be trimmed. Oral ivermectin combined with topical therapy is most effective. Control of dissemination is essential and includes isolation of patient, avoidance of skin-to-skin contact, use of gloves/gowns by staff, prophylactic treatment of contacts (entire institution and visitors or family members).

Decontamination of Environment Bedding, clothing, and towels should be decontaminated (machine washed or machine dried using heat cycle or dry-cleaned) or removed from body contact for at least 72 hours. Thorough cleaning of patient's room or residence.

Treatment of Eczematous Dermatitis Antihistamines Systemic sedating antihistamine such as hydroxyzine hydrochloride, doxepin, or diphenhydramine at bedtime.

Topical Glucocorticoid Ointment Applied to areas of extensive dermatitis associated with scabies.

Systemic Glucocorticoids Prednisone 70 mg, tapered over 1 to 2 weeks, gives symptomatic relief of severe hypersensitivity reaction.

Postscabietic Itching Generalized itchining that persists a week or more is probably caused by hypersensitivity to remaining dead mites and mite products. Nevertheless, a second treatment 7 days after the first is recommended by some physicians. For severe, persistent pruritus, especially in individuals with history of atopic disorders, a 14-day tapered course of prednisone (70 mg on day 1) is indicated.

Secondary Bacterial Infection Treat with mupirocin ointment or systemic antimicrobial agent.

Scabietic Nodules May persist in association with pruritus for up to a year after eradication of infestation. Intralesional triamcinolone, 5 to 10 mg/ml into each lesion, is effective; repeat every 2 weeks if necessary.

More Skin Disorders
 
   Langerhans Cell Histiocytosis
   Leg Ulcers
   Lentigo Maligna
   Leprosy
   Leukemia Cutis
   Livedo Reticularis
   Localized Infection
   Lupus Erythematosus
   Lyme Borreliosis
   Lymphogranuloma Venereum
   Lymphomatoid Papulosis
   Malignant Melanoma of the Mucosa
   Mammary Paget's Disease
   Mastocytosis Syndromes
   Measles
   Melasma
   Merkel Cell Carcinoma
   Metastatic Cancer to the Skin
   Molluscum Contagiosum
   Mycetoma
   Mycobacterium Fortuitum Complex Infection
   Mycobacterium Marinum Infection
   Mycobacterium Ulcerans Infection
   Necrobiosis Lipoidica
   Neisseria Gonorrhoeae Infections
   Neurofibromatosis
   Nodular Melanoma
   Nodular Vasculitis
   Nongenital Herpes Simplex Virus Infection
   North American Blastomycosis
   Onychomycosis
   Oral Hairy Leukoplakia
   Oropharyngeal Candidiasis
   Other Viral Infections
   Papulosquamous Conditions
   Pediculosis Capitis
   Pediculosis Pubis
   Pediculosis
   Photoallergic Drug Induced Photosensitivity
   Phototoxic Drug Induced Photosensitivity
   Phytophotodermatitis
   Pitted Keratolysis
   Pityriasis Versicolor
   Polyarteritis Nodosa
   Polymorphous Light Eruption
   Porphyria Cutanea Tarda
   Port-Wine Stain
   Premalignant and Malignant Skin Tumors
   Pressure Ulcers
   Pruritic Urticarial Papules
   Pseudoxanthoma Elasticum
   Pyogenic Granuloma
   Radiation Dermatitis
   Raynaud's Disease
   Reiter's Syndrome
   Rocky Mountain Spotted Fevers
   Rosacea
   Rubella
   Xanthelasma
   Xanthomas
   X-Linked Hyper-IgM Syndrome
   Xeroderma Pigmentosum
   Yaws
   Yellow Fever
   Yellow Nail Syndrome
   Zygomycete
   Zinc Deficiency

Skin Disorders || Contact Us || Tweet

Copyright © Skin-disorders.net All Rights Reserved.

Disclaimer - The data contained in the Skin-disorders.net Web pages is provided for the purpose of educational purposes and information only. It is not intended nor implied to be a substitute for professional medical advice and shall not create a physician - patient relationship. We are not responsible for any consequence resulted from using this information. Please always consult your physician for medical advices and treatment.